- Laboratory >
- Laboratory medicine >
- Clinical reagent >
- SENTINEL
SENTINEL clinical reagents
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... -Ideal solution for screening of community and population -Applicable on most common clinical chemistry analyzers -High performance, ready-to-use reagents, long shelf life and onboard stability -Avoid ...
SENTINEL DIAGNOSTICS
... Calibrators -Sensitivity (LoD): 5 copies/reaction -Validated on CFX96™ (Bio-Rad) and QuantStudio™ 5 (ABI) -CE IVD reagent STAT-NAT® BKV kit is available in an open configuration, validated on the most common ...
SENTINEL DIAGNOSTICS
... Calibrators -Sensitivity (LoD): 10 copies/reaction -Validated on CFX96™ (Bio-Rad) and QuantStudio™ 5 (ABI) -CE IVD reagent STAT-NAT® EBV kit is available in an open configuration, validated on the most common ...
SENTINEL DIAGNOSTICS
... Specificity ≥95% -Sensitivity (LoD): 5 copies/reaction -Validated on CFX96™ (Bio-Rad) and QuantStudio™ 5 (ABI) -CE IVD reagent STAT-NAT® HHV-6 kit is available in an open configuration, validated on the most ...
SENTINEL DIAGNOSTICS
... Specificity ≥95% -Sensitivity (LoD): 10 copies/reaction -Validated on CFX96™ (Bio-Rad) and QuantStudio™ 5 (ABI) -CE IVD reagent STAT-NAT® HSV-1 kit is available in an open configuration, validated on the most ...
SENTINEL DIAGNOSTICS
... Specificity ≥95% -Sensitivity (LoD): 10 copies/reaction -Validated on CFX96™ (Bio-Rad) and QuantStudio™ 5 (ABI) -CE IVD reagent STAT-NAT® HSV-2 kit is available in an open configuration, validated on the most ...
SENTINEL DIAGNOSTICS
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining